Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States

Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States

Adherence challenges with oral pre-exposure prophylaxis have stimulated interest in alternate modes of administration including long-acting injections. We conducted 30 in-depth interviews with 26 male trial participants and 4 clinical providers in a Phase IIa study (ÉCLAIR) evaluating the use of lo...

Full description

Bibliographic Details
Main Authors: Beckham, S.W (Author), Defechereux, P. (Author), Grant, R. (Author), Hammond, P. (Author), Kerrigan, D. (Author), La Mar, M. (Author), Mantsios, A. (Author), Margolis, D. (Author), Markowitz, M. (Author), Murray, M. (Author)
Format: Article
Language:English
Published: Springer New York LLC 2018
Subjects:
adult
Adult
anti human immunodeficiency virus agent
Anti-HIV Agents
cabotegravir
California
clinical trial (topic)
Clinical Trials as Topic
Cross-Sectional Studies
cross-sectional study
decision making
Decision Making
female
Female
HIV
HIV Infections
human
Human immunodeficiency virus infection
Humans
interview
Interviews as Topic
Long-acting injectable
male
Male
Men
middle aged
Middle Aged
New York
pre-exposure prophylaxis
Pre-Exposure Prophylaxis
PrEP
Providers
pyridone derivative
Pyridones
Qualitative
qualitative research
Qualitative Research
recording
Risk behavior
San Francisco
Tape Recording
United States
young adult
Young Adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items